In CRC, alterations in CD4+ T-cell responses, including subset distribution and functional adaptability, reshape the equilibrium between tumor-promoting and tumor-suppressive immunity in accordance with the prevailing inflammatory context [46–48]. This evidence concerns the gene CD4 and colorectal carcinoma.